959-52-4

Applied Filters:

Keyword:'959-52-4'

Showing 1-2 of 2 results for "959-52-4" within Papers

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.

Guo-Rui Ruan et al.

Annals of hematology, 88(2), 159-166 (2008-08-30)

Recently, mutations in the nucleophosmin (NPM1) gene were detected in 50-60% of adult acute myelogenous leukemia (AML) patients, mainly with a normal karyotype. In this study, we detected typical NPM1 mutations (types A, B, D) in untreated Chinese AML patients

Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.

Fernando J Martinez et al.

Lancet (London, England), 385(9971), 857-866 (2015-02-17)

Roflumilast reduces exacerbations in patients with severe chronic obstructive pulmonary disease. Its effect in patients using fixed combinations of inhaled corticosteroids and longacting β2 agonists is unknown. We postulated that roflumilast would reduce exacerbations in patients with severe chronic obstructive

Page 1 of 1